EcoDrugPlus

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSJJAG00000007664
Gene Symbol: MST1R
2 Cross references
266 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSJJAG00000010013
Gene Symbol: MMP1
2 Cross references
352 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSJJAG00000019762
Gene Symbol: MMP12
3 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSJJAG00000013818
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSJJAG00000005540
Gene Symbol: MMP14
3 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSJJAG00000010703
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSJJAG00000009326
Gene Symbol: MMP7
3 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSJJAG00000021566
Gene Symbol: MMP8
3 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSJJAG00000011491
Gene Symbol: MMP9
3 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSJJAG00000012490
Gene Symbol: MTOR
3 Cross references
214 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSJJAG00000002102
Gene Symbol: MC3R
3 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSJJAG00000006252
Gene Symbol: MC4R
3 Cross references
121 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).